Is CI stock a Buy, Sell, or Hold?

Based on our analysis, CI is currently a WAIT with low confidence. 📊 MIXED SIGNALS: CI shows conflicting indicators. Wait for confirmation before entering.

What is the fair value of CI stock?

Our analysis estimates the fair value range for CI to be between $271.44 and $283.35. The current price is $270.53.

What is the analyst price target for CI?

The average Wall Street analyst price target for CI is $341.04. This implies a potential upside of 27.3% from current levels.

The Cigna Group (CI) Stock: Buy, Sell, or Hold?

CI - The Cigna Group

HOSPITAL & MEDICAL SERVICE PLANS

$270.53

2.57 (0.96%) ▲

5d: -0.54%

30d: -4.35%

90d: -4.06%

WAIT

LOW Confidence

Protect Your CI Gains

Analysis Updated: Oct 2, 2026 12:00 AM ET

Earnings: Oct 29, 2026 26d

Smart Money Accumulation

Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →

Signal fired Sep 28, 2026 at $271.83 · last confirmed Oct 1, 2026

Strength: 7.6/10

Get Alerted When CI Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 MIXED SIGNALS: CI shows conflicting indicators. Wait for confirmation before entering.

See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: 9.6%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$394.49

Based on 6.8% avg growth

INTRINSIC VALUE TODAY

$244.95

Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 8.5x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: CI is currently trading at $270.53, which is considered oversold relative to its 30-day fair value range of $271.44 to $283.35. The stock's valuation (Forward PE: 8.0) is in line with its historical norms (8.5). Remarkably, the market is currently pricing in an annual earnings decline of 2.1% over the next few years. This pessimistic expectation contrasts with the company's recent 10.2% earnings growth, suggesting potential undervaluation if the company simply maintains stability.

Technical Outlook: Technically, CI is in a downtrend. The price is currently testing key support at $262.85. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: The stock scores a mixed 53/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $341.04 (+27.3%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD

Historical Trading Range $271.44 - $283.35

Company Quality Score 51/100 (HOLD)

Volume Confirmation HIGH

Confidence Score 79.5%

Protect Your Profits

Holding CI? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

BULLISH: Price oversold vs 30-day range
NEUTRAL: Mixed technical signals (53/100)
BULLISH: High volume confirmation
BULLISH: Trading 27.3% below Wall St target ($341.04)
WARNING: Composite score 51/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $271.44 - $283.35

Current vs Trading Range OVERSOLD

Support & Resistance Levels

Support Level $262.85

Resistance Level $278.88

Current Trend Downtrend

Technical data as of Oct 2, 2026

Fundamental Context

Forward P/E (Next Year Est.) 8.02

Wall Street Target $341.04 (+27.3%)

Revenue Growth (YoY) 6.7%

Earnings Growth (YoY) 10.2%

Profit Margin 2.3%

Valuation Discount vs History -2.1% cheaper

PE vs Historical 8.0 vs 8.5 FAIR

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): -2.1% (market-implied from PE analysis)

1-Year Target $262.33 (-2%)

2-Year Target $256.82 (-4%)

3-Year Target $251.43 (-6%)

3-Yr Target (if PE normalizes) (PE: 8→9) $266.63 (-1%)

3-Year Scenarios Using analyst projected EPS growth

Bull: (PE: 20.4, Growth: 9.6%) $897.13 (+235%)

Base: (SPY PE: 8.0, Growth: 9.6%) $352.50 (+32%)

Bear: (PE: 6.8, Growth: 9.6%) $299.63 (+12%)

📈 Valuation based on Current Earnings

RECOVERY PLAY: Stock looks expensive now (11x PE), but valuation improves significantly next year (8x PE) as earnings recover.

Trailing PE: 11.24 | Current EPS (TTM): $24.19

Bull Case $413.23 (+54%)

Analyst growth 38.2%, PE expands to 12.4

Base Case $375.66 (+40%)

Market implied 38.2%, PE stable at 11.2

Bear Case $184.84 (-31%)

Severe decline -20.0%, PE contracts to 9.6

These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.

💡 Upside Surprise Potential

If earnings stabilize (0% growth), PE could expand from 8.0 to 8.5

Stabilization Target: $284.15 (+6.0%)

PE Expansion Potential: +6.0%

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: October 02, 2026 3:58 PM ET
Data refreshes hourly during market hours. Next update: 4:58 PM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is CI showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

NEUTRAL

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for CI.

Create Free Account

Already have an account? Log In

Top Rated Healthcare Plans Stocks

Top-rated stocks in Healthcare Plans by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
CVS CVS Health Corp	STRONG BUY 28 analysts	$116	66 BUY
UNH UnitedHealth Group Incor…	STRONG BUY 27 analysts	$482	56 HOLD
ELV Elevance Health Inc	STRONG BUY 22 analysts	$451	45 HOLD
HUM Humana Inc	HOLD 26 analysts	$424	65 BUY
CNC Centene Corp	BUY 19 analysts	$72	54 HOLD

CVS CVS Health Corp

66 BUY

UNH UnitedHealth Grou…

56 HOLD

ELV Elevance Health I…

Advanced CI Option Strategies

Professional options setups generated by AI based on today's CI price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for CI

CI Technical Chart CI Price Prediction CI Earnings Date CI Investment Advisor CI Fair Price Analyzer CI Options Advisor CI Options Chain CI Options Analysis CI Competitors

Compare CI with Peers

CI vs HUM
Which one to buy?

CI vs CNC
Which one to buy?

CI vs HCA
Which one to buy?

CI vs CAH
Which one to buy?

CI vs MCK
Which one to buy?

TRUP vs CI
Winner: CI

Create New Comparison View All Competitors

Tradestie